Kyungdong Pharm banner
K

Kyungdong Pharm
KOSDAQ:011040

Watchlist Manager
Kyungdong Pharm
KOSDAQ:011040
Watchlist
Price: 5 700 KRW -0.18% Market Closed
Market Cap: ₩153.9B

Kyungdong Pharm
Research & Development

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Kyungdong Pharm
Research & Development Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
K
Kyungdong Pharm
KOSDAQ:011040
Research & Development
-₩4.7B
CAGR 3-Years
11%
CAGR 5-Years
-6%
CAGR 10-Years
1%
Yuhan Corp
KRX:000100
Research & Development
-₩197B
CAGR 3-Years
-19%
CAGR 5-Years
-10%
CAGR 10-Years
-19%
SK Biopharmaceuticals Co Ltd
KRX:326030
Research & Development
-₩162.2B
CAGR 3-Years
-12%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
Hanmi Pharm Co Ltd
KRX:128940
Research & Development
-₩189.1B
CAGR 3-Years
-9%
CAGR 5-Years
4%
CAGR 10-Years
-1%
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Research & Development
-₩8.7B
CAGR 3-Years
-8%
CAGR 5-Years
17%
CAGR 10-Years
-9%
C
Caregen Co Ltd
KOSDAQ:214370
Research & Development
-₩5.7B
CAGR 3-Years
3%
CAGR 5-Years
-5%
CAGR 10-Years
N/A
No Stocks Found

Kyungdong Pharm
Glance View

Market Cap
153.9B KRW
Industry
Pharmaceuticals

KYUNG DONG PHARMACEUTICAL Co., Ltd. engages in the manufacture and sale of medicines for liver therapy, gastrointestinal, antimigrain, osteoporosis, cardiovascular, antiviral, antiobesity, muscle relaxant, neuropathic, antibacterial, antidiabetic, central nervous system, antifungal, urology, antispasmodic, pain and inflammation, antihistamine, vitamin, repiratory, antiinflammatory enzyme, respiratory and others. The company is headquartered in Hwaseong, Gyeonggi-Do. is a Korea-based company engaged in the manufacture and marketing of pharmaceutical products. The Company’s products include liver therapies, gastrointestinal drugs, antimigraine drugs, antiviral, anti-obesity medications, antibacterial drugs, antidiabetic drugs, antifungal, allergy medications, antispasmodics, antihistamines, vitamins, as well as drugs for osteoporosis, cardiovascular, muscle relaxant, neuropathic and other diseases. The company also provides various over-the-counter (OTC) drugs, such as anti-inflammatory medicines, antiviral drugs, antihistamine drugs, gastrointestinal drugs and others. In addition, the Company engages in the leasing of real estate, and distribution of snowboards and health functional food.

Intrinsic Value
6 304.98 KRW
Undervaluation 10%
Intrinsic Value
Price
K

See Also

What is Kyungdong Pharm's Research & Development?
Research & Development
-4.7B KRW

Based on the financial report for Sep 30, 2025, Kyungdong Pharm's Research & Development amounts to -4.7B KRW.

What is Kyungdong Pharm's Research & Development growth rate?
Research & Development CAGR 10Y
1%

Over the last year, the Research & Development growth was 28%. The average annual Research & Development growth rates for Kyungdong Pharm have been 11% over the past three years , -6% over the past five years , and 1% over the past ten years .

Back to Top